DOLF reaches final stage of onchocerciasis clinical trial in Liberia

A WashU Medicine-led research team is nearing a major milestone in a clinical trial in Liberia aimed at improving treatment for onchocerciasis, or river blindness. The study, Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis, has reached its final stage, with participants undergoing final examinations and surgical nodule removal procedures 24 months after initial treatment.